Article Details
Retrieved on: 2023-10-14 04:49:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related ...
Article found on: www.digitaljournal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here